{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-052675","form_type":"8-K","ticker":"NOTV","cik":"0000720154","company_name":"Inotiv, Inc.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.002064+00:00","generated_at":"2026-05-16T19:31:50.656415+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Inotiv prelim Q4 revenue $137.5-138.5M; full year $512.5-513.5M; DSA awards up 60% YoY","bullets":["Preliminary Q4 FY2025 revenue $137.5-138.5M, improving over prior year; full year $512.5-513.5M.","DSA book-to-bill ~1.08x in Q4 and ~1.05x for FY2025; backlog $138.0M at Sept 30, 2025.","DSA contract awards in Q4 increased 60% year-over-year.","Full fiscal 2025 audited results expected in early December 2025.","CEO Robert Leasure Jr. to present at Jefferies Global Healthcare Conference Nov 18 at 6:00 AM ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-052675","json":"https://secwatch.observer/filing/0001628280-25-052675.json","markdown":"https://secwatch.observer/filing/0001628280-25-052675.md","text":"https://secwatch.observer/filing/0001628280-25-052675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/720154/000162828025052675/0001628280-25-052675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/720154/000162828025052675/notv-20251117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:31:50.656415+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}